Dana-Farber/Harvard SPORE in Breast Cancer
达纳法伯/哈佛孢子在乳腺癌中的应用
基本信息
- 批准号:7676025
- 负责人:
- 金额:$ 217.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
This application is for the first renewal of the Dana-Farber/Harvard SPORE in Breast Cancer, funded October 1, 2000. This SPORE is a component of the Breast Cancer Program in the Dana-Farber/Harvard Comprehensive Cancer Center (DF/HCC), and includes investigators from all major DF/HCC sites, Harvard University and MIT. Six Projects are proposed: Project 1 seeks common molecular pathways shared by basal-like and BRCA1 -linked cancers, and proposes a preoperative clinical trial in HER2-and ER-negative cancers. Project 2 will improve the treatment of HER2-positive cancer by searching for new targets and new drugs to use in combination with trastuzumab. Project 3 examines the response of ER-positive cancers to aromatase inhibitors, focusing on the role of coactivators and receptor occupancy of ER target sequences. Project 4 addresses the conundrum of metastasis using genomic approaches to study human primary and metastatic disease. Project 5 examines the role of tumor - stromal interactions in the early breast neoplasia, and seeks diagnostic and therapeutic targets that are active in this interaction. Project 6 will combine functional studies in cells and tissues with population-based research to seek alleles of kinase genes associated with increased risk. These Projects will be supported by the following Core Resources: Tissue and Pathology, providing a range of tissues and services; Clinical Studies, managing the interface between research and patients (recruitment, consent, and registration); Cohort Studies, managing and maintaining databases of research and clinical resources; Biostatistics, providing statistical consultation to SPORE investigators; and Bioinformatics to manage large genomic data sets and provide initial consultation to investigators seeking analytical help. The Harvard SPORE will devote 13% of its direct research costs to Career Development and Developmental Projects, and proposes selection and evaluation processes. The Communication, Planning and Administration Core will continually improve the SPORE by evaluating, planning and modifying our research to maximize our impact on breast cancer.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC P WINER其他文献
ERIC P WINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC P WINER', 18)}}的其他基金
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
SPORE:丹娜—法伯癌症研究所/哈佛大学癌症中心 SPORE 在乳腺癌中的应用
- 批准号:
8607752 - 财政年份:2013
- 资助金额:
$ 217.95万 - 项目类别:
Administration, Advocacy, Planning and Communication Core
行政、宣传、规划和沟通核心
- 批准号:
8607757 - 财政年份:2013
- 资助金额:
$ 217.95万 - 项目类别:
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
SPORE:丹娜—法伯癌症研究所/哈佛大学癌症中心 SPORE 在乳腺癌中的应用
- 批准号:
8735888 - 财政年份:2013
- 资助金额:
$ 217.95万 - 项目类别:
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition
项目 1 - 克服乳腺癌对 CDK4/6 抑制的耐药性
- 批准号:
10668342 - 财政年份:2013
- 资助金额:
$ 217.95万 - 项目类别:
相似海外基金
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Dana Farber/哈佛大学癌症中心 SPORE 在肺癌中的应用
- 批准号:
10673920 - 财政年份:2022
- 资助金额:
$ 217.95万 - 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10024413 - 财政年份:2020
- 资助金额:
$ 217.95万 - 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10228046 - 财政年份:2020
- 资助金额:
$ 217.95万 - 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10684196 - 财政年份:2020
- 资助金额:
$ 217.95万 - 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10469368 - 财政年份:2020
- 资助金额:
$ 217.95万 - 项目类别:
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
丹娜—法伯癌症研究所/哈佛大学癌症中心 ET-CTN,重点为 I 期
- 批准号:
9242737 - 财政年份:2014
- 资助金额:
$ 217.95万 - 项目类别:
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Dana-Farber/哈佛大学癌症中心实验治疗临床试验网络网站(DF/HCC ETCTN 网站)
- 批准号:
10784840 - 财政年份:2014
- 资助金额:
$ 217.95万 - 项目类别:
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site) - Incorporation of Mayo Clinic Cancer Center as an Affiliated Center
Dana-Farber/哈佛大学癌症中心实验治疗临床试验网络网站(DF/HCC ETCTN 网站)- 梅奥诊所癌症中心并入附属中心
- 批准号:
10393266 - 财政年份:2014
- 资助金额:
$ 217.95万 - 项目类别:
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
丹娜—法伯癌症研究所/哈佛大学癌症中心 ET-CTN,重点为 I 期
- 批准号:
8725826 - 财政年份:2014
- 资助金额:
$ 217.95万 - 项目类别:
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
丹娜—法伯癌症研究所/哈佛大学癌症中心 SPORE 在乳腺癌中的应用
- 批准号:
10668334 - 财政年份:2013
- 资助金额:
$ 217.95万 - 项目类别: